Blog

ACM Research, Inc. (ACMR) closed at $39.45 in the latest trading session, marking a -1.87% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.74% for the day

In the latest close session, Toll Brothers (TOL) was down 1.01% at $135.22. This move lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow lost 0.63%, while the tech-heavy Nasdaq lost 0.76%

In the latest close session, AppLovin (APP) was down 2.87% at $673.82. The stock trailed the S&P 500, which registered a daily loss of 0.74%. Elsewhere, the Dow lost 0.63%, while the tech-heavy

AMC Entertainment (AMC) closed at $1.56 in the latest trading session, marking a -3.11% move from the prior day. This change lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow saw a

Super Micro Computer (SMCI) closed at $29.27 in the latest trading session, marking a -1.28% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.74% for the

For equity investors looking beyond incremental AI investments, quantum computing is emerging as one of the most lucrative opportunities heading into 2026. Industry estimates show the global quantum

In 2026, savvy investors will likely focus on companies that deliver consistent earnings growth, signaling profitability. However, earnings acceleration has an even greater effect on driving stock

Shares of Replimune Group REPL have surged 131.1% over the past three months, fueled by positive regulatory updates.

In October, the FDA accepted the resubmission of the biologics license

As I look ahead to 2026 and search for compelling investment opportunities, one productive place to focus is on stocks that lagged during an otherwise strong year for U.S. equities. The broader

Encompass Health Corporation EHC is aided by growing patient volumes, frequent expansion initiatives and a strong financial position.

EHC’s Zacks Rank & Upbeat Price Performance

Encompass Health

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering OSI Systems (OSIS), which belongs to the Zacks

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Axos Financial (AX), which belongs to the Zacks

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering K12 (LRN), which belongs to the Zacks Schools

Prenetics Global Limited (PRE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Elutia Inc. (ELUT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one

Cactus, Inc. (WHD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings

USCB Financial Holdings, Inc. (USCB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in

Acuity (AYI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most

Encompass Health (EHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Contineum Therapeutics, Inc. (CTNM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

GitLab Inc. (GTLB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even